Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7535980rdf:typepubmed:Citationlld:pubmed
pubmed-article:7535980lifeskim:mentionsumls-concept:C0004358lld:lifeskim
pubmed-article:7535980lifeskim:mentionsumls-concept:C0027015lld:lifeskim
pubmed-article:7535980lifeskim:mentionsumls-concept:C0033105lld:lifeskim
pubmed-article:7535980lifeskim:mentionsumls-concept:C0037791lld:lifeskim
pubmed-article:7535980lifeskim:mentionsumls-concept:C2825347lld:lifeskim
pubmed-article:7535980pubmed:issue10lld:pubmed
pubmed-article:7535980pubmed:dateCreated1995-5-11lld:pubmed
pubmed-article:7535980pubmed:abstractTextThe prevalence and specificity of naturally occurring human IgA anti-IgE autoantibodies (a-E Ab) were studied by ELISA with anti-IgA monoclonal antibodies (mAb) and a purified myeloma IgE as solid-phase protein, i.e., IgE-DES(kappa). Such detected IgA a-E Ab were common among adults, and significantly increased geometric means (GM) were found in patients with atopy (P = 0.006; n = 41; GM = 79.3 arbitrary units (AU)/ml) and filariasis (P = 0.02; n = 41; GM = 75.9 AU/ml), as compared with nonatopic controls (n = 42; GM = 48.8 AU/ml). No such difference was observed between age-matched nonatopic (n = 22; GM = 36.7 AU/ml) and atopic (n = 22; GM = 38.6 AU/ml) children. Children had significantly (P < 0.001) lower IgA a-E Ab concentrations than adults, probably as a result of age, because IgA a-E Ab concentrations and age of children were significantly correlated (n = 44; P < 0.05; r = 0.30). IgA a-E Ab concentrations were very low in cord serum (n = 32; median < 0.1 AU/ml). Sex did not influence IgA a-E Ab concentrations in any study group. The specificity of IgA a-E Ab in nine sera was studied by ELISA inhibition assay using IgE-DES myeloma as solid-phase protein and inhibitory proteins of the IgG, IgM, IgD, and IgE classes, including five different IgE myeloma proteins, as well as three enzymatic fragments of IgE-DES. The inhibitions indicated that all IgA a-E Ab tested reacted in a low-affinity reaction with determinants restricted to IgE-DES, i.e., the solid-phase protein.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:7535980pubmed:languageenglld:pubmed
pubmed-article:7535980pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7535980pubmed:citationSubsetIMlld:pubmed
pubmed-article:7535980pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7535980pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7535980pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7535980pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7535980pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7535980pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7535980pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7535980pubmed:statusMEDLINElld:pubmed
pubmed-article:7535980pubmed:monthDeclld:pubmed
pubmed-article:7535980pubmed:issn0105-4538lld:pubmed
pubmed-article:7535980pubmed:authorpubmed-author:MagnussonC...lld:pubmed
pubmed-article:7535980pubmed:issnTypePrintlld:pubmed
pubmed-article:7535980pubmed:volume49lld:pubmed
pubmed-article:7535980pubmed:ownerNLMlld:pubmed
pubmed-article:7535980pubmed:authorsCompleteYlld:pubmed
pubmed-article:7535980pubmed:pagination820-6lld:pubmed
pubmed-article:7535980pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7535980pubmed:meshHeadingpubmed-meshheading:7535980-...lld:pubmed
pubmed-article:7535980pubmed:meshHeadingpubmed-meshheading:7535980-...lld:pubmed
pubmed-article:7535980pubmed:meshHeadingpubmed-meshheading:7535980-...lld:pubmed
pubmed-article:7535980pubmed:meshHeadingpubmed-meshheading:7535980-...lld:pubmed
pubmed-article:7535980pubmed:meshHeadingpubmed-meshheading:7535980-...lld:pubmed
pubmed-article:7535980pubmed:meshHeadingpubmed-meshheading:7535980-...lld:pubmed
pubmed-article:7535980pubmed:meshHeadingpubmed-meshheading:7535980-...lld:pubmed
pubmed-article:7535980pubmed:meshHeadingpubmed-meshheading:7535980-...lld:pubmed
pubmed-article:7535980pubmed:meshHeadingpubmed-meshheading:7535980-...lld:pubmed
pubmed-article:7535980pubmed:meshHeadingpubmed-meshheading:7535980-...lld:pubmed
pubmed-article:7535980pubmed:meshHeadingpubmed-meshheading:7535980-...lld:pubmed
pubmed-article:7535980pubmed:meshHeadingpubmed-meshheading:7535980-...lld:pubmed
pubmed-article:7535980pubmed:meshHeadingpubmed-meshheading:7535980-...lld:pubmed
pubmed-article:7535980pubmed:meshHeadingpubmed-meshheading:7535980-...lld:pubmed
pubmed-article:7535980pubmed:year1994lld:pubmed
pubmed-article:7535980pubmed:articleTitleNaturally occurring human IgA autoantibodies against IgE-DES myeloma protein. Prevalence and specificity.lld:pubmed
pubmed-article:7535980pubmed:affiliationDepartment of Clinical Immunology, Karolinska Institute, Stockholm, Sweden.lld:pubmed
pubmed-article:7535980pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7535980pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed